(Press-News.org) Monica Wojcik, MD, MPH, FAAP, FACMG is the recipient of the ACMG Foundation for Genetic and Genomic Medicine’s 2025 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award—the “Watson Award”—named for the American College of Medical Genetics and Genomics’ first and longstanding executive director, Michael S. Watson, MS, PhD, FACMG.
“I am incredibly thrilled and humbled to receive this award, and I hope that my career will continue to honor the legacy of Dr. Watson, towards a future where all families can receive the care that they want and need, empowered by genetics and genomics,” said Dr. Wojcik.
“The ACMG Foundation is thrilled to have chosen Dr. Wojcik as the 2025 recipient of the Michael S. Watson Award. Her work to champion the understanding and treatment of rare diseases from fetal to neonatal care is tremendous. She exemplifies the aims of this prestigious ACMG Foundation award,” said Nancy J. Mendelsohn, MD, FACMG, president of the ACMG Foundation.
Dr. Wojcik is a neonatologist and clinical geneticist at Boston Children’s Hospital and an assistant professor in pediatrics at Harvard Medical School who specializes both clinically and academically in rare diseases affecting the fetus and neonate. Following her pediatric residency, she pursued combined fellowship training in both neonatology and genetics and subsequently obtained her Master of Public Health degree to augment her clinical effectiveness and health services research. She currently serves as the Director of the Neonatal Genomics Program at Boston Children’s Hospital and the Medical Director of the Manton Center for Orphan Disease Research. Dr. Wojcik’s research focuses on the application of genomic medicine in the perinatal setting, particularly related to genetic diagnosis in the neonatal intensive care unit, understanding genetic causes of perinatal mortality via genomic autopsy, and addressing inequities in rare disease genomics. In her clinical practice, she is an attending in the neonatal intensive care unit at Boston Children’s Hospital and on the inpatient genetics service, consults prenatally for complex fetal cases, and runs a multidisciplinary developmental follow-up clinic for infants with genetic conditions.
“The ACMGF is delighted to acknowledge the next generation of exceptional genetics and genomics professionals. We hope that Dr. Wojcik continues to make innovative contributions that positively impact the field for years to come,” said Melanie J. Wells, MPH, CAE, ACMG Chief Executive Officer.
About the ACMG Foundation for Genetic and Genomic Medicine
The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to “translate genes into health.” Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create “Better Health through Genetics” visit acmgfoundation.org.
Note to editors: To arrange interviews with experts in medical genetics, contact ACMG Communications Manager, Barry Eisenberg, MS at beisenberg@acmg.net.
END
Monica Hsiung Wojcik, MD, MPH, FAAP, FACMG is the recipient of the 2025 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine
2025-03-19
ELSE PRESS RELEASES FROM THIS DATE:
Kiely N. James, PhD, FACMG receives the 2025 Richard King Award for Best Publication by a Trainee in Genetics in Medicine
2025-03-19
Kiely N. James, PhD, FACMG is the recipient of the 2025 Richard King Trainee Award. This award was instituted by the ACMG Foundation for Genetic and Genomic Medicine to encourage American Board of Medical Genetics and Genomics (ABMGG), international equivalents, or genetic counseling trainees in their careers and to foster the publication of the highest quality research in Genetics in Medicine (GIM), an official journal of the ACMG.
Each year the editorial board reviews all articles published in GIM by eligible trainees who were either a first or corresponding author during that year. The manuscript considered to have the ...
The ACMG Foundation for Genetic and Genomic Medicine presents four next generation Fellowship Awards at the 2025 ACMG Annual Clinical Genetics Meeting
2025-03-19
Each year, the ACMG Foundation for Genetic and Genomic Medicine grants its Next Generation Fellowship awards to promising early career professionals in a range of medical genetics and genomics specialties including Clinical Genetics, Clinical Biochemical Genetics, Laboratory Genetics and Genomics, Medical Biochemical Genetics and Ophthalmic Genetics. Support for this year’s class of fellows was generously provided by Bionano, Pfizer, Sanofi, Spark Therapeutics, and Takeda. The ACMG Foundation depends on corporate donations ...
Marine animals help solve ocean issues
2025-03-19
Sensors attached to animals gather valuable data to track and mitigate the human influence on marine life. The Kobe University review paper emphasizes the importance of integrating data from various sources and advocates for an “Internet of Animals” based on open access and shared standards.
Humanity influences marine life through a broad range of activities, spanning from fishing and pollution to noise from boats, construction and mining. To enable a sustainable life together, we need to monitor the influence of our activities on marine life and use this ...
CNT wires for wearable electronic devices from the existing fiber manufacturing process!
2025-03-19
Dr. Han Joong Tark's team at KERI's Nano Hybrid Technology Research Center has successfully fabricated ‘functional wires’, which are the foundation of wearable electronic devices, by directly applying the existing synthetic fiber processing methods.
Wearable electronic devices, which can be attached to or worn on the body, such as on the wrist, ear, or eyes, have long become a part of our daily lives in various forms like smartwatches, glasses, and earphones. The key to these devices is that they must be lightweight while maintaining long-lasting performance. While there have been various efforts to achieve this, one of the most important elements is the conductive ...
Researchers reveal role of zeolite zcid site accessibility in syngas conversion
2025-03-19
Zeolites and zeotypes are widely used in the energy and chemical industries due to their unique pore structures and excellent shape-selective catalytic properties. However, these inherent advantages also lead to diffusion limitations, preventing guest molecules from effectively accessing internal active sites and thereby hindering catalytic efficiency.
In a study published in Angewandte Chemie International Edition, a research group led by Prof. JIAO Feng and Prof. PAN Xiulian from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences has revealed how the accessibility of ...
Gender gap in teenage depression is twice as large in London than in Tokyo, new study finds
2025-03-19
Published in The Lancet Child & Adolescent Health, the study aimed to provide robust insights into adolescent mental health trajectories in two different cultural contexts by comparing large samples of 11 to 16 years olds in London and Tokyo over time. The two studies are the Tokyo Teen Cohort (TTC) and the Resilience Ethnicity and AdolesCent Mental Health (REACH) cohorts from South London. Both groups collected data in the period 2014 to 2020 and at three different time points as the teenagers grew older.
Researchers used the Short Mood and Feelings ...
Coffee-making robot breaks new ground for AI machines
2025-03-19
An AI-powered robot that can prepare cups of coffee in a busy kitchen could usher in the next generation of intelligent machines, a study suggests.
Using a combination of cutting-edge AI, sensitive sensors and fine-tuned motor skills, the robot can interact with its surroundings in more human-like ways than ever before, researchers say.
The new technology, developed by a team at the University of Edinburgh, could transform robots’ ability to carry out tasks that previously could only be done by people.
While robots are adept at working in tightly controlled settings such as factories ...
Protecting crops: Researchers open up new avenue to combat a widespread plant virus
2025-03-19
New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture. They were developed by researchers at the Martin Luther University Halle-Wittenberg (MLU). The active ingredients have a broad spectrum effect; a series of RNA molecules support the plant's immune system in combating the virus. In laboratory experiments, 80 to 100 per cent of the treated plants survived an infection with a high viral load, as the team reports in Nucleic Acids Research. Their paper has been selected as a "breakthrough article" by the journal. The researchers are now working ...
UCLA discovers first stroke rehabilitation drug to repair brain damage
2025-03-18
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies.
The findings, published in Nature Communications, tested two candidate drugs derived from their studies on the mechanism of the brain effects of rehabilitation, of which one resulted in significant recovery in movement control after stroke in the mouse model.
Stroke is the leading cause of adult disability because most patients do not fully recover from the effects of stroke. There are no drugs in the field of stroke ...
Only around 1 in 10 common non-surgical and non-invasive treatments for back pain effective
2025-03-18
Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data analysis of the available research, published online in BMJ Evidence Based Medicine.
And the pain relief they offer is only marginally better than that achieved with a placebo, the findings indicate.
Low back pain is common and debilitating, and 80%-90% of it is categorised as non-specific, because there’s no immediately identifiable cause, note the researchers.
Non-surgical and non-invasive ...